Moreover, there was some reduction in IgG-secreting lung cells in both irinotecan-treated groups; however, the difference did not reach statistical significance (Fig. 5b ).
← all excerpts
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
1
—
—